.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Chubb
Chinese Patent Office
Medtronic
Queensland Health
Healthtrust
Novartis
Deloitte
US Department of Justice
Harvard Business School

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Other DrugPatentWatch Resources

Some biosimilars are just as good as some pricey biologics

A new study suggests that a group of biosimilar drugs, which are used to treat such afflictions as rheumatoid arthritis, psoriasis, and inflammatory bowel disease, appear as safe and effective as their more expensive brand-name counterparts, which are known as biologics. A biosimilar drug is a nearly identical variant of a biologic and is expected to…

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Request a Callback or Demo

Name: *
Email: *
Company: *
Telephone: *
Message:

Back to DrugPatentWatch Resources

For more information try a trial or see the database preview and plans and pricing

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot